Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Teva
Johnson and Johnson
Queensland Health
UBS
Boehringer Ingelheim
McKesson
US Army
Moodys

Generated: November 17, 2018

DrugPatentWatch Database Preview

Deflazacort - Generic Drug Details

« Back to Dashboard

What are the generic sources for deflazacort and what is the scope of deflazacort patent protection?

Deflazacort is the generic ingredient in one branded drug marketed by Ptc Therap and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for deflazacort. Two suppliers are listed for this compound.

Summary for deflazacort
Pharmacology for deflazacort
Synonyms for deflazacort
(11beta,16beta)-21-(Acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione
(11beta,16beta)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate
11beta,21-Dihydroxy-2'-methyl-5'betaH-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione 21-acetate
11beta,21-dihydroxy-2'-methyl-5'betaH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 2'-acetate
14484-47-0
2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a,10-trimethyl-4-oxo-1,2,4,6a,6b,7,8,8a,11a,12,12a,12b-dodecahydro-8bH-naphtho[2',1':4,5]indeno[1,2-d]oxazol-8b-yl)-2-oxoethyl acetate
2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-HYDROXY-6,9,13-TRIMETHYL-16-OXO-5-OXA-7-AZAPENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOSA-6,14,17-TRIEN-8-YL]-2-OXOETHYL ACETATE
2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acetate
4'H-Pregna-1,4-dieno(16,17-d)oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2'-methyl-, (11beta,16beta)-
484D470
5'-beta-H-Pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11-beta,21-dihydroxy-2'-methyl-, 21-acetate
5'H-Pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 21-(acetyloxy)-11-hydroxy-2'-methyl-, (11beta,16beta)-
AB01274724_02
AB01274724-01
AB2000350
AC1L4PC6
ACN-043364
AK322033
AKOS015895199
Azacort
azacortinol
C-22370
C25H31NO6
Calcort
CAS-14484-47-0
CC-26308
CCG-220817
CHEBI:135720
CHEMBL1201891
Cortax
Cortax;Decortil;Deflanil;Calcort
CS-2349
D03671
D4523
DB11921
Decortil
Deflan
Deflanil
Deflazacort (Calcort)
Deflazacort (USAN/INN)
Deflazacort [USAN:INN:BAN]
Deflazacort, >=98% (HPLC)
Deflazacort, United States Pharmacopeia (USP) Reference Standard
Deflazacortum
Deflazacortum [INN-Latin]
Dezacor
dezacort
DL-458-IT
DL-458IT
DR002729
DSSTox_CID_378
DSSTox_GSID_20378
DSSTox_RID_75552
DTXSID9020378
EINECS 238-483-7
Emflaza
Enzocort
Flantadin
GTPL9477
H894
HY-13609
KR5YZ6AE4B
KS-1158
L-5458
Lantadin
MDL 458
MDL-458
MFCD00866106
MolPort-003-846-170
NCGC00255189-01
NCGC00263521-01
Oxazacort
PL046242
Pregna-1,4-diene-11,21-diol(17alpha,16alpha-d)2'-methyloxazoline-3,20-dione-21-acetate
pregna-1,4-diene-11beta,21-diol-3,20-dione[17alpha,16alpha-d]-2'-methyloxazoline 21-acetate
Q-101371
RL01810
s1888
SCHEMBL4018
ST51052738
Tox21_112506
Tox21_112506_1
Tox21_301415
UNII-KR5YZ6AE4B
Zamene
ZINC4212809

US Patents and Regulatory Information for deflazacort

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ptc Therap EMFLAZA deflazacort TABLET;ORAL 208684-004 Feb 9, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ptc Therap EMFLAZA deflazacort TABLET;ORAL 208684-002 Feb 9, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ptc Therap EMFLAZA deflazacort SUSPENSION;ORAL 208685-001 Feb 9, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ptc Therap EMFLAZA deflazacort TABLET;ORAL 208684-004 Feb 9, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ptc Therap EMFLAZA deflazacort TABLET;ORAL 208684-001 Feb 9, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ptc Therap EMFLAZA deflazacort TABLET;ORAL 208684-001 Feb 9, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Teva
Johnson and Johnson
Queensland Health
UBS
Boehringer Ingelheim
McKesson
US Army
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.